Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
1.410
+0.020 (1.44%)
At close: Nov 4, 2024, 4:00 PM
1.390
-0.020 (-1.43%)
After-hours: Nov 4, 2024, 7:34 PM EST
Intelligent Bio Solutions Cash Flow Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Jun '24 Jun 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
| Net Income | -10.16 | -10.16 | -10.63 | -8.31 | -7.04 | -3.16 | |
| Depreciation & Amortization | 1.21 | 1.21 | 0.97 | - | - | - | |
| Asset Writedown & Restructuring Costs | - | - | 4.16 | 2.6 | - | - | |
| Loss (Gain) on Equity Investments | - | - | - | - | 0.14 | -0.12 | |
| Stock-Based Compensation | 0.23 | 0.23 | 0.26 | - | - | - | |
| Provision & Write-off of Bad Debts | 0.01 | 0.01 | - | - | - | - | |
| Other Operating Activities | -0.16 | -0.16 | -2.21 | -0.09 | 0.55 | 0.16 | |
| Change in Accounts Receivable | -0.14 | -0.14 | -0.29 | - | - | 0.12 | |
| Change in Inventory | 0.2 | 0.2 | -0.35 | - | - | - | |
| Change in Accounts Payable | -0.63 | -0.63 | 0.08 | 0.24 | -0.97 | 2.41 | |
| Change in Other Net Operating Assets | -0.14 | -0.14 | 0.63 | 2.2 | -3.97 | 0.1 | |
| Operating Cash Flow | -9.57 | -9.57 | -7.38 | -3.36 | -11.3 | -0.5 | |
| Capital Expenditures | -0.22 | -0.22 | -0.51 | -0.38 | - | - | |
| Cash Acquisitions | - | - | -0.19 | - | - | - | |
| Investment in Securities | - | - | - | - | - | -0.01 | |
| Other Investing Activities | - | - | - | -0.5 | - | - | |
| Investing Cash Flow | -0.22 | -0.22 | -0.69 | -0.88 | - | -0.01 | |
| Short-Term Debt Repaid | - | - | - | - | - | -0.15 | |
| Total Debt Repaid | - | - | - | - | - | -0.15 | |
| Net Debt Issued (Repaid) | - | - | - | - | - | -0.15 | |
| Issuance of Common Stock | 14.56 | 14.56 | 2.55 | - | 22.11 | - | |
| Repurchase of Common Stock | - | - | -0.01 | - | - | - | |
| Other Financing Activities | - | - | -1.33 | - | -2 | -0.12 | |
| Financing Cash Flow | 14.56 | 14.56 | 1.44 | - | 23.4 | 0.73 | |
| Foreign Exchange Rate Adjustments | -0 | -0 | -0.06 | -0.1 | 0.04 | 0.01 | |
| Net Cash Flow | 4.77 | 4.77 | -6.7 | -4.34 | 12.15 | 0.23 | |
| Free Cash Flow | -9.79 | -9.79 | -7.88 | -3.74 | -11.3 | -0.5 | |
| Free Cash Flow Margin | -314.71% | -314.71% | -627.15% | - | -570.39% | -264.18% | |
| Free Cash Flow Per Share | -6.15 | -6.15 | -94.16 | -61.18 | -260.32 | -14.06 | |
| Cash Interest Paid | - | - | - | - | 0.19 | 0.33 | |
| Levered Free Cash Flow | -5.87 | -5.87 | -3.67 | -1.56 | -6.54 | 0.59 | |
| Unlevered Free Cash Flow | -5.76 | -5.76 | -3.53 | -1.56 | -5.85 | 0.87 | |
| Change in Net Working Capital | 0.56 | 0.56 | -1.02 | -4.03 | 2.59 | -1.6 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.